Active Ingredient: Budesonide
Treatment of signs and symptoms of nasal polyps.
For this indication, competent medicine agencies globally authorize below treatments:
For:
Regimen A, in the case that patient age in years is ≥ 6 :
Nasal, 256 micrograms budesonide, once daily at morning.
Regimen B, in the case that patient age in years is ≥ 6 :
Nasal, 128 micrograms budesonide, 2 times daily.
The recommended dose for the treatment of nasal polyps is 256 micrograms. The dose may be administered once daily in the morning or divided into two administrations, in the morning and in the evening.
2 actuations into each nostril once daily in the morning or
1 actuation into each nostril in the morning and in the evening
Children should be treated under guidance of an adult.
After the desired clinical effect has appeared, the lowest dose should be chosen that keeps the patient without symptoms.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.